Journey Medical第三季度每股收益$（0.09）错过$（0.04）估计，销售额1，763.1万美元错过1，885.4万美元估计

Journey Medical (NASDAQ: DERM) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.04) by 143.24 percent. This is a 25 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $17.631 million which missed the analyst consensus estimate of $18.854 million by 6.49 percent. This is a 20.52 percent increase over sales of $14.629 million the same period last year.